Neo Pharma: Pioneering Pharmaceutical Excellence:
Founded in 2003, Neo Pharma has rapidly evolved into a beacon of pharmaceutical innovation. With an initial investment of USD25 million, our first manufacturing facility set the stage for a revolutionary journey in the healthcare sector. Today, Neo Pharma, also known as Neopharma Inc, operates ten state-of-the-art manufacturing facilities across three continents, reinforcing our commitment to providing world-class pharmaceuticals at affordable prices.
A Global Leader in Pharmaceutical Manufacturing:
At Neo Pharma, we pride ourselves on a diverse portfolio of over 100 high-quality molecules. Our therapeutic segments span across vital areas such as anti-infectives, neurology, cardiology, orthopedics, diabetology, gastroenterology, urology, dermatology, gynecology, respiratory, dental, and nutritionals. Our dedication to innovation is evident in our research-driven approach, focusing on developing patent non-infringing processes and products.
Neo Pharma Wholesale: A Trusted Partner in Healthcare:
Neo Pharma Wholesale is a trusted name in the pharmaceutical industry, offering a comprehensive selection of both branded and generic formulations, as well as active pharmaceutical ingredients (APIs). Our wholesale division is dedicated to meeting the needs of distributors and healthcare providers worldwide, ensuring a steady supply of essential medications.
Global Reach, Local Impact:
Our global presence, with over 50 international markets including the Middle East, Africa, CIS, Far East, and South East Asia, is a testament to our commitment to making a positive
impact on global health. We believe in the power of local manufacturing to bring world-class healthcare solutions to communities around the world.
Commitment to Quality and Safety:
Neopharma's journey towards excellence is marked by significant partnerships and achievements, including joint ventures with industry leaders like Biocon India, Hetero Drugs, SBI Pharmaceuticals, ASKA Pharmaceuticals, and Laxai Life Sciences. Our manufacturing agreements with global giants such as Merck Sereno, Pfizer, and GSK, and our acquisitions, including Kyowa Criticare's injectable facility in Japan, highlight our expansive reach and dedication to quality.
